Q1 2015

Source filing unavailable

Q1 2015 · —

Revenue

$0.00

no prior Q1 2014 on file

Net Income

-$63.81K

no prior Q1 2014 on file

EPS Diluted

-$0.13

no prior Q1 2014 on file

Operating Income-$64,021—

Operating Cash Flow-$81,157—

Free Cash Flowderived

Same quarter

no prior Q1 2014 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Panacea Life Sciences Holdings, Inc. · CIK 1552189 · Engraved from SEC EDGAR